ESN Cleer 

Repurposed treatment for orphan cardiomyopathies

OWNER

Leo de Bruin (See Profile)


Sector

Biotech

Stage

Prototyping, preclinical

Country

Australia


Novel Composition of Matter, positive Freedom-To-Operate and First-in-Class.

Repurposed orphan drug, never marketed, off-patent, new novel synthesis and formulation.

IND (FDA) in 2024 and completing Clinical Trial phase II in 2025.

Historical superior efficacy compared to original class competitors, within Heart Failure syndrome.

Projected €5B sales with dedicated team led by seasoned and accomplished biotech entrepreneur.

Status

Approved

IP Type

Patent

Time

20 years

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Methods for diagnosis of early stage heart failure

Know more of this patent

View more

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Biomarker identification for imminent and/or impending heart failure

Know more of this patent

View more

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

BIOMARKER AND DRUG COMBINATIONS FOR HEART FAILURE PREDICTION

Know more of this patent

View more

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

(confidential – Synthesis of ESNtx005)

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

(confidential – Composition of Matter)

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 15th of September 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar